BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117:1499-1506. [PMID: 21098742 DOI: 10.1182/blood-2010-07-295444] [Cited by in Crossref: 329] [Cited by in F6Publishing: 252] [Article Influence: 29.9] [Reference Citation Analysis]
Number Citing Articles
1 Clark R, Lindsey D, Whiteway S, Mikita C, Lieuw K. Dysfunctional Immune System Reconstitution After Rituximab Exposure In Utero. J Pediatr Hematol Oncol 2021;43:e601-4. [PMID: 32590421 DOI: 10.1097/MPH.0000000000001871] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Andreoli L, Fredi M, Nalli C, Reggia R, Lojacono A, Motta M, Tincani A. Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. Journal of Autoimmunity 2012;38:J197-208. [DOI: 10.1016/j.jaut.2011.11.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
3 Makol A, Wright K, Amin S. Rheumatoid Arthritis and Pregnancy: Safety Considerations in Pharmacological Management. Drugs 2011;71:1973-87. [DOI: 10.2165/11596240-000000000-00000] [Cited by in Crossref: 53] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
4 Al-Husban N, Al-Kuran O. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature. J Med Case Rep 2018;12:147. [PMID: 29855343 DOI: 10.1186/s13256-018-1692-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tourte M, Brunet-Possenti F, Mignot S, Gavard L, Descamps V. Pemphigoid gestationis: a successful preventive treatment by rituximab. J Eur Acad Dermatol Venereol 2017;31:e206-7. [PMID: 27606493 DOI: 10.1111/jdv.13962] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
6 De Cock D, Birmingham L, Watson KD, Kearsley-Fleet L, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium. Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab. Rheumatology (Oxford) 2017;56:661-3. [PMID: 28137762 DOI: 10.1093/rheumatology/kew493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Luttwak E, Gurevich-Shapiro A, Azem F, Lishner M, Klieger C, Herishanu Y, Perry C, Avivi I. Novel agents for the treatment of lymphomas during pregnancy: A comprehensive literature review. Blood Rev 2021;49:100831. [PMID: 33931297 DOI: 10.1016/j.blre.2021.100831] [Reference Citation Analysis]
8 Pfaller B, José Yepes-Nuñez J, Agache I, Akdis CA, Alsalamah M, Bavbek S, Bossios A, Boyman O, Chaker A, Chan S, Chatzipetrou A, du Toit G, Jutel M, Kauppi P, Kolios A, Li C, Matucci A, Marson A, Bendien S, Palomares O, Rogala B, Szepfalusi Z, Untersmayr E, Vultaggio A, Eiwegger T. Biologicals in atopic disease in pregnancy: An EAACI position paper. Allergy 2021;76:71-89. [PMID: 32189356 DOI: 10.1111/all.14282] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
9 Fakhouri F, Scully M, Provôt F, Blasco M, Coppo P, Noris M, Paizis K, Kavanagh D, Pène F, Quezada S, Hertig A, Kissling S, O'Brien P, Delmas Y, Alberio L, Winer N, Veyradier A, Cataland S, Frémeaux-Bacchi V, Loirat C, Remuzzi G, Tsatsaris V. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. Blood 2020;136:2103-17. [PMID: 32808006 DOI: 10.1182/blood.2020005221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Daher A, Sauvetre G, Girszyn N, Verspyck E, Levesque H, Le Besnerais M. Granulomatosis with polyangiitis and pregnancy: A case report and review of the literature. Obstet Med. 2020;13:76-82. [PMID: 32714439 DOI: 10.1177/1753495x18822581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Bazzani C, Andreoli L, Agosti M, Nalli C, Tincani A. Antirheumatic drugs and reproduction in women and men with chronic arthritis. RMD Open 2015;1:e000048. [PMID: 26557371 DOI: 10.1136/rmdopen-2015-000048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
12 Thöne J, Thiel S, Gold R, Hellwig K. Treatment of multiple sclerosis during pregnancy - safety considerations. Expert Opin Drug Saf 2017;16:523-34. [PMID: 28333552 DOI: 10.1080/14740338.2017.1311321] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
13 Mehta P, Dorsey-Campbell R, Dassan P, Nelson-Piercy C, Viegas S. Difficult case: rituximab in anti-SRP antibody myositis in pregnancy. Pract Neurol 2019;19:444-6. [PMID: 30979789 DOI: 10.1136/practneurol-2018-002168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
14 Nguyen TG, Ward CM, Morris JM. To B or not to B cells-mediate a healthy start to life. Clin Exp Immunol 2013;171:124-34. [PMID: 23286939 DOI: 10.1111/cei.12001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
15 Colla L, Diena D, Rossetti M, Manzione AM, Marozio L, Benedetto C, Biancone L. Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era. J Nephrol 2018;31:361-83. [DOI: 10.1007/s40620-018-0477-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
16 Chon AH, Chan R, Lee RH, Kwong K, Wertheimer FB, Weitz IC. Multidrug Therapy for Refractory Immune Thrombocytopenia in Pregnancy. Obstet Gynecol 2020;135:723-7. [PMID: 32028499 DOI: 10.1097/AOG.0000000000003699] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Sun D, McLeod A, Gandhi S, Malinowski AK, Shehata N. Anemia in Pregnancy: A Pragmatic Approach.Obstet Gynecol Surv. 2017;72:730-737. [PMID: 29280474 DOI: 10.1097/OGX.0000000000000510] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 6.7] [Reference Citation Analysis]
18 Limaye MA, Buyon JP, Cuneo BF, Mehta-Lee SS. A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenat Diagn 2020;40:1066-76. [PMID: 32282083 DOI: 10.1002/pd.5709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
19 Hou S. Pregnancy in renal transplant recipients. Adv Chronic Kidney Dis 2013;20:253-9. [PMID: 23928390 DOI: 10.1053/j.ackd.2013.01.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
20 Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120:960-969. [PMID: 22740443 DOI: 10.1182/blood-2011-12-309153] [Cited by in Crossref: 145] [Cited by in F6Publishing: 124] [Article Influence: 16.1] [Reference Citation Analysis]
21 Kaplan TB. Management of Demyelinating Disorders in Pregnancy. Neurol Clin 2019;37:17-30. [PMID: 30470273 DOI: 10.1016/j.ncl.2018.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
22 Blom K, Odutayo A, Bramham K, Hladunewich MA. Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines. Clin J Am Soc Nephrol 2017;12:1862-72. [PMID: 28522651 DOI: 10.2215/CJN.00130117] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 11.8] [Reference Citation Analysis]
23 Lavi N, Horowitz NA, Brenner B. An Update on the Management of Hematologic Malignancies in Pregnancy. Womens Health (Lond Engl) 2014;10:255-66. [DOI: 10.2217/whe.14.17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
24 Amit O, Barzilai M, Avivi I. Management of Hematologic Malignancies: Special Considerations in Pregnant Women. Drugs 2015;75:1725-38. [PMID: 26416583 DOI: 10.1007/s40265-015-0464-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
25 Pavanello F, Zucca E, Ghielmini M. Rituximab: 13 open questions after 20years of clinical use. Cancer Treatment Reviews 2017;53:38-46. [DOI: 10.1016/j.ctrv.2016.11.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
26 Kilian A, Chock YP, Huang IJ, Graef ER, Upton LA, Khilnani A, Krupnikova SDS, Almaghlouth I, Cappelli LC, Fernandez-Ruiz R, Frankel BA, Frankovich J, Harrison C, Kumar B, Monga K, Vega JAR, Singh N, Sparks JA, Sullo E, Young KJ, Duarte-Garcia A, Putman M, Johnson S, Grainger R, Wallace ZS, Liew JW, Jayatilleke A. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review. Semin Arthritis Rheum 2020;50:1191-201. [PMID: 32931985 DOI: 10.1016/j.semarthrit.2020.07.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
27 Shirley E, Chakravarty EF. Treatment of Systemic Lupus Erythematosus (SLE) in Pregnancy. Curr Treat Options in Rheum 2018;4:110-8. [DOI: 10.1007/s40674-018-0085-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Gogia M, Furst DE. Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation. Drug Dev Res 2011;72:689-702. [DOI: 10.1002/ddr.20478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Koren G, Carey N, Gagnon R, Maxwell C, Nulman I, Senikas V. Cancer Chemotherapy and Pregnancy. Journal of Obstetrics and Gynaecology Canada 2013;35:263-78. [DOI: 10.1016/s1701-2163(15)30999-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 8] [Article Influence: 6.1] [Reference Citation Analysis]
30 Carnovale C, Parisi F, Battini V, Zavatta A, Cheli S, Cattaneo D, Gringeri M, Mosini G, Guarnieri G, Cammarata G, Cetin I. The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. Pharmacol Res 2021;171:105786. [PMID: 34314858 DOI: 10.1016/j.phrs.2021.105786] [Reference Citation Analysis]
31 Pendergraft WF, McGrath MM, Murphy AP, Murphy P, Laliberte KA, Greene MF, Niles JL. Fetal outcomes after rituximab exposure in women with autoimmune vasculitis. Ann Rheum Dis. 2013;72:2051-2053. [PMID: 23864238 DOI: 10.1136/annrheumdis-2013-203833] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
32 Woodrick RS, Ruderman EM. Safety of biologic therapy in rheumatoid arthritis. Nat Rev Rheumatol 2011;7:639-52. [DOI: 10.1038/nrrheum.2011.145] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
33 Busse M, Campe KJ, Nowak D, Schumacher A, Plenagl S, Langwisch S, Tiegs G, Reinhold A, Zenclussen AC. IL-10 producing B cells rescue mouse fetuses from inflammation-driven fetal death and are able to modulate T cell immune responses. Sci Rep 2019;9:9335. [PMID: 31249364 DOI: 10.1038/s41598-019-45860-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
34 Genovese G, Derlino F, Berti E, Marzano AV. Treatment of Autoimmune Bullous Diseases During Pregnancy and Lactation: A Review Focusing on Pemphigus and Pemphigoid Gestationis. Front Pharmacol 2020;11:583354. [PMID: 33117178 DOI: 10.3389/fphar.2020.583354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Berkhout A, Clark JE, Wen SC. In utero exposure to biologic disease-modifying anti-rheumatic drugs and effects to the infant: infectious complications, vaccine response, and safety of live vaccine administration. Expert Rev Vaccines 2019;18:495-504. [PMID: 30916600 DOI: 10.1080/14760584.2019.1599286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Jakiel G, Ciebiera M, Słabuszewska-Jóźwiak A, Horosz B, Bińkowska M, Wilińska M, Malec-Milewska M. Successful obstetric and hematologic outcome of aplastic anemia in a pregnant Jehovah's Witness. Int J Immunopathol Pharmacol 2016;29:543-8. [PMID: 27381285 DOI: 10.1177/0394632016656188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
37 Kushner CJ, Concha JSS, Werth VP. Treatment of Autoimmune Bullous Disorders in Pregnancy. Am J Clin Dermatol 2018;19:391-403. [DOI: 10.1007/s40257-018-0342-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
38 Hepner A, Negrini D, Hase EA, Exman P, Testa L, Trinconi AF, Filassi JR, Francisco RPV, Zugaib M, O'Connor TL, Martin MG. Cancer During Pregnancy: The Oncologist Overview. World J Oncol 2019;10:28-34. [PMID: 30834049 DOI: 10.14740/wjon1177] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
39 Mcginley MP, Moss BP, Cohen JA. Safety of monoclonal antibodies for the treatment of multiple sclerosis. Expert Opinion on Drug Safety 2017;16:89-100. [DOI: 10.1080/14740338.2017.1250881] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
40 Paydas S. Management of hemopoietic neoplasias during pregnancy. Critical Reviews in Oncology/Hematology 2016;104:52-64. [DOI: 10.1016/j.critrevonc.2016.05.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
41 Tavakolpour S, Alesaeidi S, Darvishi M, GhasemiAdl M, Darabi-Monadi S, Akhlaghdoust M, Elikaei Behjati S, Jafarieh A. A comprehensive review of rituximab therapy in rheumatoid arthritis patients. Clin Rheumatol 2019;38:2977-94. [PMID: 31367943 DOI: 10.1007/s10067-019-04699-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
42 Guzelant AY, Isyar M, Yilmaz İ, Sirin DY, Cakmak S, Mahirogullari M. Are chondrocytes damaged when rheumatologic inflammation is suppressed? Drug Chem Toxicol 2017;40:13-23. [PMID: 27079996 DOI: 10.3109/01480545.2016.1166249] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
43 Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood 2013;121:38-47. [DOI: 10.1182/blood-2012-08-448944] [Cited by in Crossref: 135] [Cited by in F6Publishing: 81] [Article Influence: 16.9] [Reference Citation Analysis]
44 Huang Q, Xie Y, Hu Z, Tang X. Anti-N-methyl-D-aspartate receptor encephalitis: A review of pathogenic mechanisms, treatment, prognosis. Brain Res. 2020;1727:146549. [PMID: 31726044 DOI: 10.1016/j.brainres.2019.146549] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
45 Thomas RM, Colon A, Motaparthi K. Rituximab in autoimmune pemphigoid diseases: Indications, optimized regimens, and practice gaps. Clin Dermatol 2020;38:384-96. [PMID: 32563354 DOI: 10.1016/j.clindermatol.2019.07.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
46 Kronbichler A, Windpessl M, Pieringer H, Jayne DRW. Rituximab for immunologic renal disease: What the nephrologist needs to know. Autoimmun Rev 2017;16:633-43. [PMID: 28414152 DOI: 10.1016/j.autrev.2017.04.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
47 Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158:323-335. [PMID: 22624596 DOI: 10.1111/j.1365-2141.2012.09167.x] [Cited by in Crossref: 453] [Cited by in F6Publishing: 311] [Article Influence: 50.3] [Reference Citation Analysis]
48 Tavakolpour S, Mirsafaei HS, Delshad S. Management of pemphigus disease in pregnancy. Am J Reprod Immunol 2017;77:e12601. [DOI: 10.1111/aji.12601] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
49 Varytė G, Zakarevičienė J, Ramašauskaitė D, Laužikienė D, Arlauskienė A. Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy's Impact on Disease Activity. Medicina (Kaunas) 2020;56:E49. [PMID: 31973138 DOI: 10.3390/medicina56020049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Harrington P, Nelson-Piercy C, Williamson C, Cooper N, Kesse-Adu R, Robinson S. Refractory severe immune thrombocytopenia in a twin pregnancy. Obstet Med 2018;11:35-8. [PMID: 29636813 DOI: 10.1177/1753495X17709188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
51 Dauti A, Gerstl B, Chong S, Chisholm O, Anazodo A. Improvements in Clinical Trials Information Will Improve the Reproductive Health and Fertility of Cancer Patients. J Adolesc Young Adult Oncol 2017;6:235-69. [PMID: 28207285 DOI: 10.1089/jayao.2016.0084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
52 Cohen JB, Blum KA. Evaluation and management of lymphoma and leukemia in pregnancy. Clin Obstet Gynecol. 2011;54:556-566. [PMID: 22031246 DOI: 10.1097/GRF.0b013e318236e68a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
53 Levin S, Rimmer K, Vargas WS. Neuroimmunologic disorders in pregnancy. Handb Clin Neurol 2020;172:105-23. [PMID: 32768083 DOI: 10.1016/B978-0-444-64240-0.00006-4] [Reference Citation Analysis]
54 Brenner B, Avivi I, Lishner M. Haematological cancers in pregnancy. The Lancet 2012;379:580-7. [DOI: 10.1016/s0140-6736(11)61348-2] [Cited by in Crossref: 105] [Cited by in F6Publishing: 16] [Article Influence: 11.7] [Reference Citation Analysis]
55 Wiles KS, Nelson-piercy C, Bramham K. Reproductive health and pregnancy in women with chronic kidney disease. Nat Rev Nephrol 2018;14:165-84. [DOI: 10.1038/nrneph.2017.187] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 13.3] [Reference Citation Analysis]
56 Schwab R, Anic K, Hasenburg A. Cancer and Pregnancy: A Comprehensive Review. Cancers (Basel) 2021;13:3048. [PMID: 34207252 DOI: 10.3390/cancers13123048] [Reference Citation Analysis]
57 Ghanima W, Gernsheimer T, Kuter DJ. How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment. Blood 2021;137:2736-44. [PMID: 33827138 DOI: 10.1182/blood.2021010968] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Lightstone L, Hladunewich MA. Lupus Nephritis and Pregnancy: Concerns and Management. Semin Nephrol 2017;37:347-53. [PMID: 28711073 DOI: 10.1016/j.semnephrol.2017.05.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
59 Ateka-Barrutia O, Khamashta MA. The challenge of pregnancy for patients with SLE. Lupus 2013;22:1295-308. [PMID: 24098002 DOI: 10.1177/0961203313504637] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
60 Perrotta K, Kiernan E, Bandoli G, Manaster R, Chambers C. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series. Rheumatol Adv Pract 2021;5:rkaa074. [PMID: 33521513 DOI: 10.1093/rap/rkaa074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
61 Prakash J, Ganiger VC. Acute Kidney Injury in Pregnancy-specific Disorders. Indian J Nephrol 2017;27:258-70. [PMID: 28761227 DOI: 10.4103/0971-4065.202406] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
62 Decroocq J, Marcellin L, Le Ray C, Willems L. Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. Obstet Gynecol 2014;124:481-3. [PMID: 25004319 DOI: 10.1097/AOG.0000000000000371] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 3.9] [Reference Citation Analysis]
63 Fakhouri F, Vercel C, Frémeaux-Bacchi V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol 2012;7:2100-6. [PMID: 22879435 DOI: 10.2215/CJN.13121211] [Cited by in Crossref: 89] [Cited by in F6Publishing: 30] [Article Influence: 9.9] [Reference Citation Analysis]
64 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
65 De Lorenzo R, Ramirez GA, Punzo D, Lorioli L, Rovelli R, Canti V, Barera G, Rovere-Querini P. Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives. Pharmacol Res 2020;152:104583. [PMID: 31816434 DOI: 10.1016/j.phrs.2019.104583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Lim AYL, Mattke AC, Clark JE, Pinzon-Charry A, Alphonso N, Kapur N. Acquired Immunodeficiency from Maternal Chemotherapy and Severe Primary Pneumocystis Infection in an Infant. Case Rep Pediatr 2020;2020:5740304. [PMID: 32257491 DOI: 10.1155/2020/5740304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Mena-vazquez N. Safety of biologic therapies during pregnancy in women with rheumatic disease. WJR 2015;5:82. [DOI: 10.5499/wjr.v5.i2.82] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 Khellaf M, Loustau V, Bierling P, Michel M, Godeau B. [Thrombocytopenia and pregnancy]. Rev Med Interne 2012;33:446-52. [PMID: 22742709 DOI: 10.1016/j.revmed.2012.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
69 Garip Y. Use of biologic agents for rheumatic diseases in pregnancy. WJR 2015;5:50. [DOI: 10.5499/wjr.v5.i2.50] [Reference Citation Analysis]
70 Czaja AJ. Current and prospective pharmacotherapy for autoimmune hepatitis. Expert Opin Pharmacother. 2014;15:1715-1736. [PMID: 24961409 DOI: 10.1517/14656566.2014.931938] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
71 Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, van Vollenhoven RF, Emery P; Rituximab Consensus Expert Committee. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 2011;70:909-20. [PMID: 21378402 DOI: 10.1136/ard.2010.144998] [Cited by in Crossref: 262] [Cited by in F6Publishing: 198] [Article Influence: 26.2] [Reference Citation Analysis]
72 Harris C, Marin J, Beaulieu MC. Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report. BMC Nephrol 2018;19:152. [PMID: 29954345 DOI: 10.1186/s12882-018-0949-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
73 Daver N, Nazha A, Kantarjian HM, Haltom R, Ravandi F. Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options. Clin Lymphoma Myeloma Leuk 2013;13:86-9. [PMID: 22981963 DOI: 10.1016/j.clml.2012.06.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
74 Rodeghiero F. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP. Br J Haematol 2018;181:183-95. [DOI: 10.1111/bjh.15090] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
75 Cree BA. Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis. Mult Scler 2013;19:835-43. [DOI: 10.1177/1352458512471880] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
76 Mahmoud HK, Samra MA, Fathy GM. Hematologic malignancies during pregnancy: A review. J Adv Res. 2016;7:589-596. [PMID: 27408762 DOI: 10.1016/j.jare.2016.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
77 Soh MC, Moretto M. The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy. Obstet Med 2020;13:5-13. [PMID: 32284726 DOI: 10.1177/1753495X19841799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Köhler BM, Günther J, Kaudewitz D, Lorenz HM. Current Therapeutic Options in the Treatment of Rheumatoid Arthritis. J Clin Med 2019;8:E938. [PMID: 31261785 DOI: 10.3390/jcm8070938] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 24.0] [Reference Citation Analysis]
79 Joubert B, García-Serra A, Planagumà J, Martínez-Hernandez E, Kraft A, Palm F, Iizuka T, Honnorat J, Leypoldt F, Graus F, Dalmau J. Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series. Neurol Neuroimmunol Neuroinflamm 2020;7:e668. [PMID: 31948997 DOI: 10.1212/NXI.0000000000000668] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
80 Gurevich-Shapiro A, Avivi I. Current treatment of lymphoma in pregnancy. Expert Rev Hematol 2019;12:449-59. [PMID: 31055974 DOI: 10.1080/17474086.2019.1615878] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Machen L, Clowse ME. Vasculitis and Pregnancy. Rheum Dis Clin North Am 2017;43:239-47. [PMID: 28390566 DOI: 10.1016/j.rdc.2016.12.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
82 Hashimoto Y, Omura H, Tokuyasu Y, Nakamoto S, Tanaka T. Successful Management of Primary Mediastinal Large B-cell Lymphoma during Pregnancy. Intern Med 2019;58:3455-9. [PMID: 31391392 DOI: 10.2169/internalmedicine.3129-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi S, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B. Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. Blood 2020;136:3056-61. [PMID: 32814348 DOI: 10.1182/blood.2020007594] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
84 Pham-Huy A, Top KA, Constantinescu C, Seow CH, El-Chaâr D. The use and impact of monoclonal antibody biologics during pregnancy. CMAJ 2021;193:E1129-36. [PMID: 34312166 DOI: 10.1503/cmaj.202391] [Reference Citation Analysis]
85 Andersen JB, Magyari M. Pharmacotherapeutic considerations in women with multiple sclerosis. Expert Opin Pharmacother 2020;21:1591-602. [PMID: 32521172 DOI: 10.1080/14656566.2020.1774554] [Reference Citation Analysis]
86 Fragoso YD, Adoni T, Brooks JBB, Finkelsztejn A, da Gama PD, Grzesiuk AK, Marques VD, Parolin MFK, Sato HK, Varela DL, Vasconcelos CCF. Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children. Neurol Ther 2018;7:207-32. [PMID: 30167914 DOI: 10.1007/s40120-018-0110-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
87 Czaja AJ. Management of Recalcitrant Autoimmune Hepatitis. Curr Hepatitis Rep 2013;12:66-77. [DOI: 10.1007/s11901-012-0161-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
88 Birru Talabi M, Clowse MEB. Antirheumatic medications in pregnancy and breastfeeding. Curr Opin Rheumatol. 2020;32:238-246. [PMID: 32205567 DOI: 10.1097/bor.0000000000000710] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
89 Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K. Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord 2020;13:1756286420936166. [PMID: 32655689 DOI: 10.1177/1756286420936166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
90 Zand L, Specks U, Sethi S, Fervenza FC. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities. Adv Chronic Kidney Dis. 2014;21:182-193. [PMID: 24602467 DOI: 10.1053/j.ackd.2014.01.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
91 Maggen C, van Gerwen M, Van Calsteren K, Vandenbroucke T, Amant F. Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article. Int J Gynecol Cancer 2019:ijgc-2018-000061. [PMID: 30659032 DOI: 10.1136/ijgc-2018-000061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
92 Loustau V, Pourrat O, Mandelbrot L, Godeau B. Purpura thrombopénique immunologique et grossesse : état des connaissances actuelles et questions encore sans réponse. La Revue de Médecine Interne 2015;36:167-72. [DOI: 10.1016/j.revmed.2014.07.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
93 Martínez López JA, García Vivar ML, Cáliz R, Freire M, Galindo M, Hernández MV, López Longo FJ, Martínez Taboada V, Pego Reigosa JM, Rubio E, Trujillo E, Vela-Casasempere P. Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding. Reumatol Clin 2017;13:264-81. [PMID: 27321859 DOI: 10.1016/j.reuma.2016.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
94 Veltri NL, Hladunewich M, Bhasin A, Garland J, Thomson B. De novo antineutrophil cytoplasmic antibody-associated vasculitis in pregnancy: a systematic review on maternal, pregnancy and fetal outcomes. Clin Kidney J 2018;11:659-66. [PMID: 30288261 DOI: 10.1093/ckj/sfy011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
95 Nixon A, Ogden L, Woywodt A, Dhaygude A. Infectious complications of rituximab therapy in renal disease. Clin Kidney J 2017;10:455-60. [PMID: 28852481 DOI: 10.1093/ckj/sfx038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
96 Mouyis M, Flint JD, Giles IP. Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence. Seminars in Arthritis and Rheumatism 2019;48:911-20. [DOI: 10.1016/j.semarthrit.2018.07.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
97 Tisovic K, Amezcua L. Women's Health: Contemporary Management of MS in Pregnancy and Post-Partum. Biomedicines 2019;7:E32. [PMID: 31010259 DOI: 10.3390/biomedicines7020032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
98 Lazzaroni MG, Dall’ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. Journal of Autoimmunity 2016;74:106-17. [DOI: 10.1016/j.jaut.2016.06.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 9.2] [Reference Citation Analysis]
99 Lopalco G, Rigante D, Lopalco A, Emmi G, Venerito V, Vitale A, Capozio G, Denora N, Cantarini L, Iannone F. Safety of systemic treatments for Behçet's syndrome. Expert Opin Drug Saf 2020;19:1269-301. [PMID: 32883123 DOI: 10.1080/14740338.2020.1817379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
100 Barzilai M, Avivi I, Amit O. Hematological malignancies during pregnancy. Mol Clin Oncol 2019;10:3-9. [PMID: 30655971 DOI: 10.3892/mco.2018.1759] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
101 Yan M, Malinowski AK, Shehata N. Thrombocytopenic syndromes in pregnancy. Obstet Med 2016;9:15-20. [PMID: 27512485 DOI: 10.1177/1753495X15601937] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
102 Østensen M, Förger F. How safe are anti-rheumatic drugs during pregnancy? Current Opinion in Pharmacology 2013;13:470-5. [DOI: 10.1016/j.coph.2013.03.004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
103 Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies (CNR‐MAT). TTP in the setting of pregnancy: The story still has to be written. J Thromb Haemost 2020;18:2775-7. [PMID: 33460292 DOI: 10.1111/jth.15030] [Reference Citation Analysis]
104 Krysko KM, Bove R, Dobson R, Jokubaitis V, Hellwig K. Treatment of Women with Multiple Sclerosis Planning Pregnancy. Curr Treat Options Neurol 2021;23:11. [PMID: 33814892 DOI: 10.1007/s11940-021-00666-4] [Reference Citation Analysis]
105 Fukutani Y, Chigusa Y, Kondoh E, Kawasaki K, Io S, Matsumura N. Pneumocystis Pneumonia in Non-HIV Pregnant Women Receiving Chemotherapy for Malignant Lymphoma: Two Case Reports. Case Rep Obstet Gynecol 2017;2017:1073146. [PMID: 28932610 DOI: 10.1155/2017/1073146] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Martinez-martinez MU, Baranda-candido L, Gonzalez-amaro R, Perez-ramirez O, Abud-mendoza C. Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman. Rheumatology 2013;52:405-6. [DOI: 10.1093/rheumatology/kes164] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
107 Schioppo T, Ingegnoli F. Current perspective on rituximab in rheumatic diseases. Drug Des Devel Ther 2017;11:2891-904. [PMID: 29042750 DOI: 10.2147/DDDT.S139248] [Cited by in Crossref: 46] [Cited by in F6Publishing: 16] [Article Influence: 11.5] [Reference Citation Analysis]
108 Esteve-Solé A, Luo Y, Vlagea A, Deyà-Martínez Á, Yagüe J, Plaza-Martín AM, Juan M, Alsina L. B Regulatory Cells: Players in Pregnancy and Early Life. Int J Mol Sci 2018;19:E2099. [PMID: 30029515 DOI: 10.3390/ijms19072099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
109 Boulay H, Mazaud-Guittot S, Supervielle J, Chemouny JM, Dardier V, Lacroix A, Dion L, Vigneau C. Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review. Clin Kidney J 2021;14:1871-8. [PMID: 34345409 DOI: 10.1093/ckj/sfab049] [Reference Citation Analysis]
110 Miyamoto S, Yamada M, Kasai Y, Miyauchi A, Andoh K. Anticancer drugs during pregnancy. Jpn J Clin Oncol 2016;46:795-804. [PMID: 27284093 DOI: 10.1093/jjco/hyw073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
111 Gomez-Lopez N, Romero R, Hassan SS, Bhatti G, Berry SM, Kusanovic JP, Pacora P, Tarca AL. The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study. Front Immunol 2019;10:2863. [PMID: 31921132 DOI: 10.3389/fimmu.2019.02863] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
112 Schleiss MR. Cytomegalovirus in the neonate: immune correlates of infection and protection. Clin Dev Immunol 2013;2013:501801. [PMID: 24023565 DOI: 10.1155/2013/501801] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
113 Wang HF, Liang MY, Jiang Q. [Management of patients with lymphoma in pregnancy]. Zhonghua Xue Ye Xue Za Zhi 2020;41:1053-6. [PMID: 33445860 DOI: 10.3760/cma.j.issn.0253-2727.2020.12.019] [Reference Citation Analysis]
114 Fouda GG, Martinez DR, Swamy GK, Permar SR. The Impact of IgG transplacental transfer on early life immunity. Immunohorizons 2018;2:14-25. [PMID: 29457151 DOI: 10.4049/immunohorizons.1700057] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 25.7] [Reference Citation Analysis]
115 Avivi I, Farbstein D, Brenner B, Horowitz NA. Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries. Blood Rev. 2014;28:213-220. [PMID: 25108745 DOI: 10.1016/j.blre.2014.06.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
116 Mao-Draayer Y, Thiel S, Mills EA, Chitnis T, Fabian M, Katz Sand I, Leite MI, Jarius S, Hellwig K. Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations. Nat Rev Neurol 2020;16:154-70. [PMID: 32080393 DOI: 10.1038/s41582-020-0313-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
117 Hou S. A woman with GN presenting during pregnancy. Clin J Am Soc Nephrol 2013;8:1027-33. [PMID: 23184566 DOI: 10.2215/CJN.06370612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
118 Miranda-Acuña J, Rivas-Rodríguez E, Levy M, Ansari M, Stone R, Patel V, Amezcua L. Rituximab during pregnancy in neuromyelitis optica: A case report. Neurol Neuroimmunol Neuroinflamm 2019;6:e542. [PMID: 30800724 DOI: 10.1212/NXI.0000000000000542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
119 Østensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse ME, Costedoat-Chalumeau N, Cutolo M, Dolhain R, Fenstad MH, Förger F, Wahren-Herlenius M, Ruiz-Irastorza G, Koksvik H, Nelson-Piercy C, Shoenfeld Y, Tincani A, Villiger PM, Wallenius M, von Wolff M. State of the art: Reproduction and pregnancy in rheumatic diseases. Autoimmun Rev 2015;14:376-86. [PMID: 25555818 DOI: 10.1016/j.autrev.2014.12.011] [Cited by in Crossref: 119] [Cited by in F6Publishing: 97] [Article Influence: 17.0] [Reference Citation Analysis]
120 Cardiel MH, Carrillo S, Pérez M, Andrade L, Pacheco Tena C, Silveira LH, Limón L, Cerpa S, Gutiérrez Ureña S, Durán S, Irazoque Palazuelos F, Muñoz López S, Sicsik Ayala SA, Barile L, Ramos Sánchez MA, Grajeda Portes D, Portela M, Hernández Bedolla A, García-Figueroa JL, Montero M, Abud-Mendoza C, Martínez Martínez MU, Herrera van Ostdam D, Pascual-Ramos V, Merayo-Chalico J, Guzmán-Sánchez I, Pérez-Bastidas ME, Aguilar Arreola JE, López Rodríguez A, Reyes-Cordero G, Ricardez HA, Hernández Cabrera MF, Olvera-Soto G, Xibillé Friedmann D. Update of the Mexican College of Rheumatology Guidelines for the Pharmacological Treatment of Rheumatoid Arthritis, 2018. Reumatol Clin (Engl Ed) 2021;17:215-28. [PMID: 31103432 DOI: 10.1016/j.reuma.2019.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
121 Ojeda-uribe M, Afif N, Dahan E, Sparsa L, Haby C, Sibilia J, Ternant D, Ardizzone M. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases. Clin Rheumatol 2013;32:695-700. [DOI: 10.1007/s10067-012-2156-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
122 Boere I, Lok C, Vandenbroucke T, Amant F. Cancer in pregnancy: safety and efficacy of systemic therapies. Curr Opin Oncol 2017;29:328-34. [PMID: 28614135 DOI: 10.1097/CCO.0000000000000386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
123 Brennan FR, Cauvin A, Tibbitts J, Wolfreys A. Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases. Drug Dev Res 2014;75:115-61. [PMID: 24782266 DOI: 10.1002/ddr.21173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
124 Gerosa M, Argolini LM, Artusi C, Chighizola CB. The use of biologics and small molecules in pregnant patients with rheumatic diseases. Expert Rev Clin Pharmacol 2018;11:987-98. [PMID: 30227748 DOI: 10.1080/17512433.2018.1525293] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
125 Maggen C, Wolters VERA, Cardonick E, Fumagalli M, Halaska MJ, Lok CAR, de Haan J, Van Tornout K, Van Calsteren K, Amant F; International Network on Cancer, Infertility and Pregnancy (INCIP). Pregnancy and Cancer: the INCIP Project. Curr Oncol Rep 2020;22:17. [PMID: 32025953 DOI: 10.1007/s11912-020-0862-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
126 Coyle PK, Oh J, Magyari M, Oreja-Guevara C, Houtchens M. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review. Mult Scler Relat Disord 2019;32:54-63. [PMID: 31030020 DOI: 10.1016/j.msard.2019.04.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
127 Chandra A, Midtvedt K, Åsberg A, Eide IA. Immunosuppression and Reproductive Health After Kidney Transplantation. Transplantation 2019;103:e325-33. [DOI: 10.1097/tp.0000000000002903] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
128 Chekol Abebe E, Asmamaw Dejenie T, Mengie Ayele T, Dagnew Baye N, Agegnehu Teshome A, Tilahun Muche Z. The Role of Regulatory B Cells in Health and Diseases: A Systemic Review. J Inflamm Res 2021;14:75-84. [PMID: 33469337 DOI: 10.2147/JIR.S286426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
129 Jara LJ, Cruz-Dominguez MDP, Saavedra MA. Impact of infections in autoimmune rheumatic diseases and pregnancy. Curr Opin Rheumatol 2019;31:546-52. [PMID: 31169546 DOI: 10.1097/BOR.0000000000000636] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Izak M, Bussel JB. Management of thrombocytopenia. F1000Prime Rep. 2014;6:45. [PMID: 24991422 DOI: 10.12703/p6-45] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
131 Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3:3780-817. [PMID: 31770441 DOI: 10.1182/bloodadvances.2019000812] [Cited by in Crossref: 154] [Cited by in F6Publishing: 130] [Article Influence: 154.0] [Reference Citation Analysis]
132 Neave L, Scully M. Microangiopathic Hemolytic Anemia in Pregnancy. Transfus Med Rev 2018;32:230-6. [PMID: 30177429 DOI: 10.1016/j.tmrv.2018.08.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
133 Fiascone S, Datkhaeva I, Winer ES, Rizack T. Primary mediastinal large B-cell lymphoma in pregnancy. Leukemia & Lymphoma 2015;57:240-3. [DOI: 10.3109/10428194.2015.1049168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
134 Ponticelli C, Moroni G. Fetal Toxicity of Immunosuppressive Drugs in Pregnancy. J Clin Med 2018;7:E552. [PMID: 30558290 DOI: 10.3390/jcm7120552] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
135 Soh MC, Nelson-piercy C. High-risk pregnancy and the rheumatologist. Rheumatology 2015;54:572-87. [DOI: 10.1093/rheumatology/keu394] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
136 Ngian GS, Briggs AM, Ackerman IN, Van Doornum S. Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation. Int J Rheum Dis 2016;19:834-43. [PMID: 27125255 DOI: 10.1111/1756-185X.12860] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
137 Schumacher A, Zenclussen AC. Human Chorionic Gonadotropin-Mediated Immune Responses That Facilitate Embryo Implantation and Placentation. Front Immunol 2019;10:2896. [PMID: 31921157 DOI: 10.3389/fimmu.2019.02896] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
138 Schneider J, Walz G, Neumann-Haefelin E. [Hypertensive Disorders in Pregnancy]. Dtsch Med Wochenschr 2021;146:279-86. [PMID: 33592664 DOI: 10.1055/a-1233-7685] [Reference Citation Analysis]
139 Vasanthamohan L, Choo S, Marshall T, Symons YT, Matsui D, Eastabrook G, Solh Z. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review. Transfusion 2020;60:2448-55. [PMID: 32851670 DOI: 10.1111/trf.16003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Whittam DH, Tallantyre EC, Jolles S, Huda S, Moots RJ, Kim HJ, Robertson NP, Cree BAC, Jacob A. Rituximab in neurological disease: principles, evidence and practice. Pract Neurol 2019;19:5-20. [PMID: 30498056 DOI: 10.1136/practneurol-2018-001899] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
141 Kim S, Huh S, Jang H, Park NY, Kim Y, Jung JY, Lee MY, Hyun J, Kim HJ. Outcome of pregnancies after onset of the neuromyelitis optica spectrum disorder. Eur J Neurol 2020;27:1546-55. [DOI: 10.1111/ene.14274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
142 Hyrich KL, Verstappen SM. Biologic therapies and pregnancy: the story so far. Rheumatology (Oxford). 2014;53:1377-1385. [PMID: 24352337 DOI: 10.1093/rheumatology/ket409] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 9.1] [Reference Citation Analysis]
143 Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher‐stine L, Crow‐hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol 2020;72:529-56. [DOI: 10.1002/art.41191] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 78.0] [Reference Citation Analysis]
144 Fabian M. Pregnancy in the Setting of Multiple Sclerosis. Continuum (Minneap Minn) 2016;22:837-50. [PMID: 27261685 DOI: 10.1212/CON.0000000000000328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
145 Kokolios M, Lamprou F, Stylianidou D, Sotiriadis D, Patsatsi A. New onset pemphigus foliaceus during pregnancy: A rare case. Int J Womens Dermatol 2018;4:109-12. [PMID: 29872686 DOI: 10.1016/j.ijwd.2017.10.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
146 Seyed Ahadi M, Sahraian MA, Baghbanian SM, Azimi A, Shaygannejad V, Anjidani N, Mohammadiani Nejad SE, Izadi S, Beladi Moghadam N, Ayromlou H, Ashtari F, Amiri A, Niknam Z, Asarzadegan F, Mazdeh M, Bayati A, Yousefi Pour GA, Yazdanbakhsh S, Naser Moghadasi A. Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study. Mult Scler Relat Disord 2021;47:102667. [PMID: 33321357 DOI: 10.1016/j.msard.2020.102667] [Reference Citation Analysis]
147 Milojkovic D, Apperley JF. How I treat leukemia during pregnancy. Blood 2014;123:974-84. [PMID: 24269956 DOI: 10.1182/blood-2013-08-283580] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
148 Fogerty AE. Thrombocytopenia in Pregnancy: Mechanisms and Management. Transfus Med Rev 2018;32:225-9. [PMID: 30177431 DOI: 10.1016/j.tmrv.2018.08.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
149 Mandal PK, Dolai TK, Bagchi B, Ghosh MK, Bose S, Bhattacharyya M. B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen. Indian J Pediatr 2014;81:1092-4. [PMID: 24562617 DOI: 10.1007/s12098-013-1336-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
150 Chen G, Crispin P, Cherian M, Dahlstrom JE, Sethna FF, Kaye G, Pavli P, Subramaniam K. Placental involvement by non-Hodgkin lymphoma in a Crohn disease patient on long-term thiopurine therapy: Placental involvement by lymphoma in IBD. Internal Medicine Journal 2016;46:102-5. [DOI: 10.1111/imj.12957] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
151 Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation. Journal of the American Academy of Dermatology 2014;70:401.e1-401.e14. [DOI: 10.1016/j.jaad.2013.09.010] [Cited by in Crossref: 98] [Cited by in F6Publishing: 60] [Article Influence: 14.0] [Reference Citation Analysis]
152 Lee EJ, Ahn KH, Hong SC, Lee EH, Park Y, Kim BS. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth. Obstet Gynecol Sci 2014;57:526-9. [PMID: 25469343 DOI: 10.5468/ogs.2014.57.6.526] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
153 Sun D, Shehata N, Ye XY, Gregorovich S, De France B, Arnold DM, Shah PS, Malinowski AK. Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy. Blood 2016;128:1329-35. [PMID: 27402971 DOI: 10.1182/blood-2016-04-710285] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
154 Shah S, Geetha D. Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. Immunotargets Ther 2015;4:173-83. [PMID: 27471722 DOI: 10.2147/ITT.S55516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
155 Micu M, Ostensen M, Villiger P, Micu R, Ionescu R. Paternal exposure to antirheumatic drugs—What physicians should know: Review of the literature. Seminars in Arthritis and Rheumatism 2018;48:343-55. [DOI: 10.1016/j.semarthrit.2018.01.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
156 Kitley J, Palace J. Therapeutic options in neuromyelitis optica spectrum disorders. Expert Review of Neurotherapeutics 2016;16:319-29. [DOI: 10.1586/14737175.2016.1150178] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
157 Poorvu PD, Frazier AL, Feraco AM, Manley PE, Ginsburg ES, Laufer MR, LaCasce AS, Diller LR, Partridge AH. Cancer Treatment-Related Infertility: A Critical Review of the Evidence. JNCI Cancer Spectr 2019;3:pkz008. [PMID: 31360893 DOI: 10.1093/jncics/pkz008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
158 Leroy C, Rigot JM, Leroy M, Decanter C, Le Mapihan K, Parent AS, Le Guillou AC, Yakoub-Agha I, Dharancy S, Noel C, Vantyghem MC. Immunosuppressive drugs and fertility. Orphanet J Rare Dis 2015;10:136. [PMID: 26490561 DOI: 10.1186/s13023-015-0332-8] [Cited by in Crossref: 84] [Cited by in F6Publishing: 68] [Article Influence: 14.0] [Reference Citation Analysis]
159 Mota LMHD, Cruz BA, Brenol CV, Pollak DF, Pinheiro GDRC, Laurindo IMM, Pereira IA, Carvalho JFD, Bertolo MB, Pinheiro MDM, Freitas MVC, Silva NAD, Louzada‐júnior P, Sampaio‐barros PD, Giorgi RDN, Lima RAC, Andrade LEC. Segurança do uso de terapias biológicas para o tratamento de artrite reumatoide e espondiloartrites. Revista Brasileira de Reumatologia 2015;55:281-309. [DOI: 10.1016/j.rbr.2014.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
160 España A, Ornilla E, Panizo C. Rituximab in dermatology. Actas Dermosifiliogr 2013;104:380-92. [PMID: 23665436 DOI: 10.1016/j.adengl.2013.04.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Donohoe F, Higgins M, Higgins S, McAuliffe F, Murphy K. Rituximab - A novel therapy for severe ITP in pregnancy: A case report. Obstet Med 2019;12:196-8. [PMID: 31853261 DOI: 10.1177/1753495X18778489] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
162 Myers B. Diagnosis and management of maternal thrombocytopenia in pregnancy. Br J Haematol 2012;158:3-15. [PMID: 22551110 DOI: 10.1111/j.1365-2141.2012.09135.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
163 Shah S, Eckstein C. B cell depletion and pregnancy: Review and applications for MS treatment. Mult Scler Relat Disord 2019;33:153-7. [PMID: 31202154 DOI: 10.1016/j.msard.2019.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken) 2020;72:461-88. [PMID: 32090466 DOI: 10.1002/acr.24130] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 37.0] [Reference Citation Analysis]
165 Stieglbauer K, Pichler R, Topakian R. 10-year-outcomes after rituximab for myasthenia gravis: Efficacy, safety, costs of inhospital care, and impact on childbearing potential. J Neurol Sci. 2017;375:241-244. [PMID: 28320139 DOI: 10.1016/j.jns.2017.02.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
166 Krause ML, Amin S, Makol A. Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know. Ther Adv Musculoskelet Dis 2014;6:169-84. [PMID: 25342996 DOI: 10.1177/1759720X14551568] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
167 Wan J, Imadojemu S, Werth VP. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum. Clinics in Dermatology 2016;34:344-52. [DOI: 10.1016/j.clindermatol.2016.02.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
168 Sica A, Vitiello P, Papa A, Calogero A, Sagnelli C, Casale D, Mottola M, Svanera G, Dodaro CA, Martinelli E, Troiani T, Ciardiello F, Casale B. Use of Rituximab in NHL Malt Type Pregnant in I° Trimester for Two Times. Open Med (Wars) 2019;14:757-60. [PMID: 31844674 DOI: 10.1515/med-2019-0087] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
169 Piatek CI, El-hemaidi I, Feinstein DI, Liebman HA, Akhtari M. Management of immune-mediated cytopenias in pregnancy. Autoimmunity Reviews 2015;14:806-11. [DOI: 10.1016/j.autrev.2015.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
170 Kim BJ, Kim HS, Kim JH, Lee KY. Moderate to Severe Thrombocytopenia During Pregnancy: A Single Institutional Experience. Indian J Hematol Blood Transfus 2017;33:581-5. [PMID: 29075073 DOI: 10.1007/s12288-017-0784-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
171 Palta A, Dhiman P. Thrombocytopenia in pregnancy. J Obstet Gynaecol 2016;36:146-52. [PMID: 26431056 DOI: 10.3109/01443615.2015.1041893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Góralczyk A, Kolossa K, Waszczak-Jeka M, Adamczak R, Jeka S. The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation. Postepy Dermatol Alergol 2020;37:306-12. [PMID: 32774212 DOI: 10.5114/ada.2020.96294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
173 Avilés A, Neri N, Nambo MJ. Hematological malignancies and pregnancy: treat or no treat during first trimester. Int J Cancer 2012;131:2678-83. [PMID: 22511239 DOI: 10.1002/ijc.27560] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
174 Eastwood-Wilshere N, Turner J, Oliveira N, Morton A. Cancer in Pregnancy. Asia Pac J Clin Oncol 2019;15:296-308. [PMID: 31436920 DOI: 10.1111/ajco.13235] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
175 Sammaritano LR, Bermas BL. Rheumatoid arthritis medications and lactation. Current Opinion in Rheumatology 2014;26:354-60. [DOI: 10.1097/bor.0000000000000055] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 3.9] [Reference Citation Analysis]
176 Lodhi FAK, Akcan T, Mojarrab JN, Sajjad S, Blonsky R. A Case of De Novo Antiglomerular Basement Membrane Disease Presenting during Pregnancy. Case Rep Nephrol 2021;2021:5539205. [PMID: 33815854 DOI: 10.1155/2021/5539205] [Reference Citation Analysis]
177 Geetha D, Kallenberg C, Stone JH, Salama AD, Appel GB, Duna G, Brunetta P, Jayne D. Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab. J Nephrol 2015;28:17-27. [PMID: 25185728 DOI: 10.1007/s40620-014-0135-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
178 Shah MR, Brandt JS, David KA, Evens AM. Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches. Curr Oncol Rep 2020;22:113. [PMID: 32804274 DOI: 10.1007/s11912-020-00972-1] [Reference Citation Analysis]
179 Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen F, Mealy MA, Sorum J, Mutch K, Tobyne SM, Ruprecht K, Buckle G, Levy M, Wingerchuk D, Paul F, Cross AH, Jacobs A, Chitnis T, Weinshenker B. High risk of postpartum relapses in neuromyelitis optica spectrum disorder. Neurology 2017;89:2238-44. [PMID: 29093070 DOI: 10.1212/WNL.0000000000004681] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
180 Langer-Gould AM. Pregnancy and Family Planning in Multiple Sclerosis. Continuum (Minneap Minn) 2019;25:773-92. [PMID: 31162316 DOI: 10.1212/CON.0000000000000745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
181 Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol 2012;158:16-29. [PMID: 22571181 DOI: 10.1111/j.1365-2141.2012.09146.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
182 Eslick R, Mclintock C. Managing ITP and thrombocytopenia in pregnancy. Platelets 2020;31:300-6. [DOI: 10.1080/09537104.2019.1640870] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
183 Kumar M, Ray L, Vemuri S, Simon TA. Pregnancy outcomes following exposure to abatacept during pregnancy. Seminars in Arthritis and Rheumatism 2015;45:351-6. [DOI: 10.1016/j.semarthrit.2015.06.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
184 Moroni G, Ponticelli C. Important considerations in pregnant patients with lupus nephritis. Expert Rev Clin Immunol 2018;14:489-98. [PMID: 29764231 DOI: 10.1080/1744666X.2018.1476139] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
185 Singh P, Dhooria A, Rathi M, Agarwal R, Sharma K, Dhir V, Nada R, Minz R, Suri V, Jain S, Sharma A. Successful treatment outcomes in pregnant patients with ANCA-associated vasculitides: A systematic review of literature. Int J Rheum Dis 2018;21:1734-40. [PMID: 30345645 DOI: 10.1111/1756-185X.13342] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
186 Hamad N, Kliman D, Best OG, Caramins M, Hertzberg M, Lindeman R, Porter R, Mulligan SP. Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management. Br J Haematol 2015;168:350-60. [PMID: 25256787 DOI: 10.1111/bjh.13134] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
187 Hui D, Hladunewich MA. Chronic Kidney Disease and Pregnancy. Obstet Gynecol. 2019;133:1182-1194. [PMID: 31135733 DOI: 10.1097/aog.0000000000003256] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 14.0] [Reference Citation Analysis]
188 Clain JM, Cartin-Ceba R, Fervenza FC, Specks U. Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis. Ther Adv Musculoskelet Dis 2014;6:58-74. [PMID: 24688606 DOI: 10.1177/1759720X13516239] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
189 Mittel RJ, Tobin MC, Kulik J. Neonatal B-cell suppression after in utero exposure to R-CHOP. Ann Allergy Asthma Immunol 2013;111:221-2. [PMID: 23987200 DOI: 10.1016/j.anai.2013.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
190 Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm 2018;5:e453. [PMID: 29564373 DOI: 10.1212/NXI.0000000000000453] [Cited by in Crossref: 88] [Cited by in F6Publishing: 33] [Article Influence: 29.3] [Reference Citation Analysis]
191 Kochhar M, Neunert C. Immune thrombocytopenia: A review of upfront treatment strategies. Blood Rev 2021;49:100822. [PMID: 33736875 DOI: 10.1016/j.blre.2021.100822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
192 Clark KE, Etomi O, Ong VH. Systemic sclerosis in pregnancy. Obstet Med 2020;13:105-11. [PMID: 33093861 DOI: 10.1177/1753495X19878042] [Reference Citation Analysis]
193 Louthrenoo W, Kasitanon N, Katchamart W, Aiewruengsurat D, Chevaisrakul P, Chiowchanwisawakit P, Dechanuwong P, Hanvivadhanakul P, Mahakkanukrauh A, Manavathongchai S, Muangchan C, Narongroeknawin P, Phumethum V, Siripaitoon B, Suesuwan A, Suwannaroj S, Uea-areewongsa P, Ukritchon S, Asavatanabodee P, Koolvisoot A, Nanagara R, Totemchokchyakarn K, Nuntirooj K, Kitumnuaypong T. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis 2017;20:1166-84. [DOI: 10.1111/1756-185x.13130] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
194 Lishner M, Avivi I, Apperley JF, Dierickx D, Evens AM, Fumagalli M, Nulman I, Oduncu FS, Peccatori FA, Robinson S, Van Calsteren K, Vandenbroucke T, Van den Heuvel F, Amant F. Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting. J Clin Oncol 2016;34:501-8. [PMID: 26628463 DOI: 10.1200/JCO.2015.62.4445] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 6.2] [Reference Citation Analysis]
195 Pinnix CC, Andraos TY, Milgrom S, Fanale MA. The Management of Lymphoma in the Setting of Pregnancy. Curr Hematol Malig Rep 2017;12:251-6. [PMID: 28470380 DOI: 10.1007/s11899-017-0386-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
196 Soh MC, Mackillop L. Biologics in pregnancy - for the obstetrician. Obstet Gynecol 2016;18:25-32. [DOI: 10.1111/tog.12250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
197 Conduit C, Yew S, Jose M, Jayne D, Kirkland G. A case of de novo diagnosis anti-neutrophil cytoplasmic antibody-negative pauci-immune necrotising glomerulonephritis in pregnancy. Intern Med J 2017;47:600-1. [PMID: 28503881 DOI: 10.1111/imj.13405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
198 Nguyen AL, Havrdova EK, Horakova D, Izquierdo G, Kalincik T, van der Walt A, Terzi M, Alroughani R, Duquette P, Girard M, Prat A, Boz C, Sola P, Ferraro D, Lugaresi A, Lechner-Scott J, Barnett M, Grand'Maison F, Grammond P, Ramo-Tello C, Turkoglu R, McCombe P, Pucci E, Trojano M, Granella F, Spitaleri D, Van Pesch V, Soysal A, Oreja-Guevara C, Verheul F, Vucic S, Hodgkinson S, Slee M, Ampapa R, Prevost J, Menoyo JLS, Skibina O, Solaro C, Olascoaga J, Shaw C, Madsen KG, Naidoo K, Hyde R, Butzkueven H, Jokubaitis V; MSBase Study Group. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study. Mult Scler Relat Disord 2019;28:235-43. [PMID: 30623864 DOI: 10.1016/j.msard.2019.01.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
199 Stojan G, Baer AN. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Review of Clinical Immunology 2014;8:439-53. [DOI: 10.1586/eci.12.36] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
200 Keskin AO, Tanburoglu A, Idiman E, Ozturk V. Anti‐ N ‐methyl‐ d ‐aspartate receptor encephalitis during pregnancy: A case report. J Obstet Gynaecol Res 2019;45:935-7. [DOI: 10.1111/jog.13892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
201 Ostensen M. Safety issues of biologics in pregnant patients with rheumatic diseases. Ann N Y Acad Sci. 2014;1317:32-38. [PMID: 24840548 DOI: 10.1111/nyas.12456] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
202 Williams M, Chakravarty EF. Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy. Curr Opin Rheumatol. 2014;26:341-346. [PMID: 24663107 DOI: 10.1097/bor.0000000000000046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
203 Kümpfel T, Thiel S, Meinl I, Ciplea AI, Bayas A, Hoffmann F, Hofstadt-van Oy U, Hoshi M, Kluge J, Ringelstein M, Aktas O, Stoppe M, Walter A, Weber MS, Ayzenberg I, Hellwig K. Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany. Neurol Neuroimmunol Neuroinflamm 2021;8:e913. [PMID: 33334856 DOI: 10.1212/NXI.0000000000000913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
204 Taulaigo AV, Moschetti L, Ganhão S, Gerardi MC, Franceschini F, Tincani A, Andreoli L. Safety considerations when using drugs in pregnant patients with systemic lupus erythematosus. Expert Opin Drug Saf 2021;20:523-36. [PMID: 33599570 DOI: 10.1080/14740338.2021.1893298] [Reference Citation Analysis]
205 Lakshmanan S, Cuker A. Contemporary management of primary immune thrombocytopenia in adults. J Thromb Haemost 2012;10:1988-98. [PMID: 22863415 DOI: 10.1111/j.1538-7836.2012.04876.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
206 Pagnoux C, Mahendira D, Laskin CA. Fertility and pregnancy in vasculitis. Best Pract Res Clin Rheumatol 2013;27:79-94. [PMID: 23507059 DOI: 10.1016/j.berh.2013.02.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
207 Fagundes PPS, Santi CG, Maruta CW, Miyamoto D, Aoki V. Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach. An Bras Dermatol 2021:S0365-0596(21)00170-7. [PMID: 34304937 DOI: 10.1016/j.abd.2020.10.007] [Reference Citation Analysis]
208 Katz-Agranov N, Khattri S, Zandman-Goddard G. The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis. Autoimmun Rev 2015;14:651-8. [PMID: 25870941 DOI: 10.1016/j.autrev.2015.04.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
209 Stang A, Schwärzler P, Schmidtke S, Tolosa E, Kobbe R. Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature. Clinical Lymphoma Myeloma and Leukemia 2020;20:e284-90. [DOI: 10.1016/j.clml.2019.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
210 Ngu S, Ngan HY. Chemotherapy in pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology 2016;33:86-101. [DOI: 10.1016/j.bpobgyn.2015.10.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
211 Pefanis A, Williams DS, Skrzypek H, Fung A, Paizis K. A case of ANCA-associated vasculitis presenting de novo in pregnancy, successfully treated with rituximab. Obstet Med 2020;13:41-4. [PMID: 32284732 DOI: 10.1177/1753495X18780853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Burnette BL, Jentoft MA, Porrata LF, Boyce TG, Witzig TE. Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management. J Clin Oncol 2014;32:e14-7. [PMID: 24395859 DOI: 10.1200/JCO.2012.47.6994] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
213 Traila A, Dima D, Achimas-Cadariu P, Micu R. Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era. Cancer Manag Res 2018;10:1517-26. [PMID: 29942153 DOI: 10.2147/CMAR.S154819] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
214 Siligato R, Gembillo G, Cernaro V, Torre F, Salvo A, Granese R, Santoro D. Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis. Front Med (Lausanne) 2020;7:563094. [PMID: 33363180 DOI: 10.3389/fmed.2020.563094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
215 Sarno MA, Mancari R, Azim HA, Colombo N, Peccatori FA. Are monoclonal antibodies a safe treatment for cancer during pregnancy? Immunotherapy 2013;5:733-41. [DOI: 10.2217/imt.13.64] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
216 Puchner A, Gröchenig HP, Sautner J, Helmy-Bader Y, Juch H, Reinisch S, Högenauer C, Koch R, Hermann J, Studnicka-Benke A, Weger W, Puchner R, Dejaco C. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.Wien Klin Wochenschr. 2019;131:29-44. [PMID: 30643992 DOI: 10.1007/s00508-019-1448-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
217 Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura. J Thromb Haemost 2020;18:2503-12. [PMID: 32914535 DOI: 10.1111/jth.15009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
218 Smith JB, Hellwig K, Fink K, Lyell DJ, Piehl F, Langer-Gould A. Rituximab, MS, and pregnancy. Neurol Neuroimmunol Neuroinflamm 2020;7:e734. [PMID: 32358226 DOI: 10.1212/NXI.0000000000000734] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 18.0] [Reference Citation Analysis]
219 Gualtierotti R, Ingegnoli F, Meroni PL. Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al. Clin Rheumatol 2013;32:727-8. [PMID: 23636791 DOI: 10.1007/s10067-013-2241-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
220 Tugizova M, Vlahovic L, Tomczak A, Wetzel NS, Han MH. New Therapeutic Landscape in Neuromyelitis Optica. Curr Treat Options Neurol 2021;23:13. [PMID: 33814893 DOI: 10.1007/s11940-021-00667-3] [Reference Citation Analysis]
221 Laws HJ, Baumann U, Bogdan C, Burchard G, Christopeit M, Hecht J, Heininger U, Hilgendorf I, Kern W, Kling K, Kobbe G, Külper W, Lehrnbecher T, Meisel R, Simon A, Ullmann A, de Wit M, Zepp F. Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020;63:588-644. [PMID: 32350583 DOI: 10.1007/s00103-020-03123-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 15.0] [Reference Citation Analysis]
222 Krause ML, Makol A. Management of rheumatoid arthritis during pregnancy: challenges and solutions. Open Access Rheumatol 2016;8:23-36. [PMID: 27843367 DOI: 10.2147/OARRR.S85340] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
223 Lambertini M, Peccatori FA, Azim HA. Targeted agents for cancer treatment during pregnancy. Cancer Treatment Reviews 2015;41:301-9. [DOI: 10.1016/j.ctrv.2015.03.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
224 Wiles K, Chappell L, Clark K, Elman L, Hall M, Lightstone L, Mohamed G, Mukherjee D, Nelson-Piercy C, Webster P, Whybrow R, Bramham K. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 2019;20:401. [PMID: 31672135 DOI: 10.1186/s12882-019-1560-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
225 Silvestris E, Cormio G, Skrypets T, Dellino M, Paradiso AV, Guarini A, Minoia C. Novel aspects on gonadotoxicity and fertility preservation in lymphoproliferative neoplasms. Crit Rev Oncol Hematol 2020;151:102981. [PMID: 32485429 DOI: 10.1016/j.critrevonc.2020.102981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Gerosa M, Meroni PL, Cimaz R. Safety considerations when prescribing immunosuppression medication to pregnant women. Expert Opinion on Drug Safety 2014;13:1591-9. [DOI: 10.1517/14740338.2014.951326] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
227 Saavedra Salinas MÁ, Barrera Cruz A, Cabral Castañeda AR, Jara Quezada LJ, Arce-salinas CA, Álvarez Nemegyei J, Fraga Mouret A, Orozco Alcalá J, Salazar Páramo M, Cruz Reyes CV, Andrade Ortega L, Vera Lastra OL, Mendoza Pinto C, Sánchez González A, Cruz Cruz PDR, Morales Hernández S, Portela Hernández M, Pérez Cristóbal M, Medina García G, Hernández Romero N, Velarde Ochoa MDC, Navarro Zarza JE, Portillo Díaz V, Vargas Guerrero A, Goycochea Robles MV, García Figueroa JL, Barreira Mercado E, Amigo Castañeda MC. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte II. Reumatología Clínica 2015;11:305-15. [DOI: 10.1016/j.reuma.2014.12.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
228 Razaz N, Piehl F, Frisell T, Langer-Gould AM, McKay KA, Fink K. Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab. Neurol Neuroimmunol Neuroinflamm 2020;7:e903. [PMID: 33087582 DOI: 10.1212/NXI.0000000000000903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
229 Ateka-Barrutia O, Nelson-Piercy C. Connective tissue disease in pregnancy. Clin Med (Lond) 2013;13:580-4. [PMID: 24298106 DOI: 10.7861/clinmedicine.13-6-580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
230 Polnaszek B, Mullen M, Bligard K, Raghuraman N, Massad LS. Term Pregnancy After Complete Response of Placental Site Trophoblastic Tumor to Immunotherapy. Obstet Gynecol 2021;138:115-8. [PMID: 34259474 DOI: 10.1097/AOG.0000000000004434] [Reference Citation Analysis]
231 Maggen C, Dierickx D, Cardonick E, Mhallem Gziri M, Cabrera-Garcia A, Shmakov RG, Avivi I, Masturzo B, Duvekot JJ, Ottevanger PB, O'Laughlin A, Polushkina E, Van Calsteren K, Woei-A-Jin FJSH, Amant F; International Network on Cancer Infertility Pregnancy (INCIP). Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy. Br J Haematol 2021;193:52-62. [PMID: 32945547 DOI: 10.1111/bjh.17103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
232 Gerosa M, Schioppo T, Meroni PL. Challenges and treatment options for rheumatoid arthritis during pregnancy. Expert Opinion on Pharmacotherapy 2016;17:1539-47. [DOI: 10.1080/14656566.2016.1197204] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
233 Raffray L, Guillevin L. Rituximab treatment of ANCA-associated vasculitis. Expert Opin Biol Ther 2020;20:899-910. [PMID: 32293192 DOI: 10.1080/14712598.2020.1748597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
234 Castro-Gutierrez A, Young K, Bermas BL. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. Med Clin North Am 2021;105:341-53. [PMID: 33589107 DOI: 10.1016/j.mcna.2020.10.002] [Reference Citation Analysis]
235 Dobson R, Dassan P, Roberts M, Giovannoni G, Nelson-Piercy C, Brex PA. UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines. Pract Neurol 2019;19:106-14. [PMID: 30612100 DOI: 10.1136/practneurol-2018-002060] [Cited by in Crossref: 56] [Cited by in F6Publishing: 34] [Article Influence: 28.0] [Reference Citation Analysis]
236 Förger F, Villiger PM. Treatment of rheumatoid arthritis during pregnancy: present and future. Expert Review of Clinical Immunology 2016;12:937-44. [DOI: 10.1080/1744666x.2016.1184973] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
237 Østensen M. The use of biologics in pregnant patients with rheumatic disease. Expert Rev Clin Pharmacol 2017;10:661-9. [PMID: 28326845 DOI: 10.1080/17512433.2017.1305268] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
238 Chakravarty EF, Sammaritano LR. Pregnancy and Autoimmune Disease, Reproductive and Hormonal Issues. Dubois' Lupus Erythematosus and Related Syndromes. Elsevier; 2019. pp. 499-519. [DOI: 10.1016/b978-0-323-47927-1.00040-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
239 El Miedany Y, Palmer D. Rheumatology-led pregnancy clinic: men perspective. Clin Rheumatol 2021;40:3067-77. [PMID: 33449229 DOI: 10.1007/s10067-020-05551-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Pishko AM, Levine LD, Cines DB. Thrombocytopenia in pregnancy: Diagnosis and approach to management. Blood Rev 2020;40:100638. [PMID: 31757523 DOI: 10.1016/j.blre.2019.100638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
241 Ciron J, Audoin B, Bourre B, Brassat D, Durand-dubief F, Laplaud D, Maillart E, Papeix C, Vukusic S, Zephir H, Marignier R, Collongues N. Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders. Revue Neurologique 2018;174:255-64. [DOI: 10.1016/j.neurol.2017.11.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
242 Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Biggioggero M, Benucci M, Li Gobbi F, Grossi V, Infantino M, Meacci F, Manfredi M, Guiducci S, Bellando-randone S, Matucci-cerinic M, Foti R, Di Gangi M, Mosca M, Tani C, Palmieri F, Goletti D. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Seminars in Arthritis and Rheumatism 2016;45:519-32. [DOI: 10.1016/j.semarthrit.2015.10.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
243 Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Giannattasio M, Gregorini G, Giacchino F, Attini R, Loi V, Limardo M, Gammaro L, Todros T, Piccoli GB. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J Nephrol 2016;29:277-303. [PMID: 26988973 DOI: 10.1007/s40620-016-0285-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 43] [Article Influence: 12.6] [Reference Citation Analysis]
244 Esteve-Solé A, Teixidó I, Deyà-Martínez A, Yagüe J, Plaza-Martín AM, Juan M, Alsina L. Characterization of the Highly Prevalent Regulatory CD24hiCD38hi B-Cell Population in Human Cord Blood. Front Immunol 2017;8:201. [PMID: 28326080 DOI: 10.3389/fimmu.2017.00201] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
245 Le Jeunne C. Risques des médicaments anti-inflammatoires et immunosuppresseurs au cours de la grossesse. La Revue de Médecine Interne 2011;32:S31-5. [DOI: 10.1016/j.revmed.2011.03.332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
246 Balbi GGM, Domingues V, Balbi GGM, De Jesús GR, Levy RA. Use of synthetic and biologic DMARDs during pregnancy. Expert Rev Clin Immunol 2019;15:27-39. [PMID: 30365902 DOI: 10.1080/1744666X.2019.1541739] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
247 Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A; British Society for Haematology. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol 2017;176:395-411. [PMID: 28005293 DOI: 10.1111/bjh.14478] [Cited by in Crossref: 76] [Cited by in F6Publishing: 53] [Article Influence: 15.2] [Reference Citation Analysis]
248 Pham-Huy A, Sadarangani M, Huang V, Ostensen M, Castillo E, Troster SM, Vaudry W, Nguyen GC, Top KA. From mother to baby: antenatal exposure to monoclonal antibody biologics. Expert Rev Clin Immunol 2019;15:221-9. [PMID: 30570400 DOI: 10.1080/1744666X.2019.1561282] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
249 Dekrem J, Van Calsteren K, Amant F. Effects of fetal exposure to maternal chemotherapy. Paediatr Drugs 2013;15:329-34. [PMID: 23856754 DOI: 10.1007/s40272-013-0040-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
250 Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clin Rev Allergy Immunol 2018;54:26-51. [PMID: 28779299 DOI: 10.1007/s12016-017-8633-4] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 24.7] [Reference Citation Analysis]
251 Ormaechea MS, Hassan M, Onghanseng N, Park JH, Mahajan S, Al-Kirwi KY, Uludag G, Halim MS, Schlaen A, Sepah YJ, Do DV, Nguyen QD. Safety of systemic therapy for noninfectious uveitis. Expert Opin Drug Saf 2019;18:1219-35. [PMID: 31801415 DOI: 10.1080/14740338.2019.1692810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Odelia A, Erel J, Chava P, Yair H, Nadav S, Michael L, Irit A. Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire. Int J Clin Oncol 2017;22:190-9. [DOI: 10.1007/s10147-016-1036-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]